Horatio Fields
Story Poster
14:29
Jake Crain talks college football's top storylines as loaded slate awaits
1 mo ago by Billy Liucci
We are blessed with a STACKED college football slate this weekend, and Jake Crain is ready for it. On Friday's edition of TexAgs Live, Crain highlighted a few of Saturday's best games and which teams should make some noise.
Story Poster
9:07
Nuño's Notes: Auburn comes to Aggieland to face No. 9 Texas A&M
1 mo ago by David Nuño
After falling in heartbreaking fashion to Oklahoma last week, Hugh Freeze and the Auburn Tigers come to College Station to face No. 9 Texas A&M at Kyle Field. Before the Ags and War Eagle do battle, David Nuño shares what he has gathered from Auburn insiders.
Story Poster
89:32
B-Team: A relegation model for CFB, Pro Football Hall of Fame nominees & more
1 mo ago by Ryan Brauninger
Late afternoons are for the B-Team as Ryan Brauninger and the crew join you on the drive home each Tuesday, Wednesday and Thursday afternoon! On Episode 14 of the B-Team, Brauny and Richard Zane discuss possible relegation in CFB, Pro Football Hall of Fame nominees and more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
46:32
Ask Liucci: Analyzing the matchups in No. 9 A&M vs. Auburn and more
1 mo ago by Billy Liucci
Southeastern Conference action returns to Kyle Field this week as the undefeated Fightin' Texas Aggies play host to Auburn in Week 5. Before War Eagle comes to Aggieland, Billy Liucci tackled another round of subscriber questions surrounding Mike Elko's Ags and beyond.
Story Poster
Tale of the Tape: No. 9 Texas A&M vs. Auburn
1 mo ago by TexAgs
After upending Notre Dame two weeks ago, the next team on No. 9 Texas A&M's revenge list is the Auburn Tigers. On Saturday afternoon at Kyle Field, the Aggies will open SEC play while also hoping to redeem themselves from last year's 43-41 quadruple-overtime loss on The Plains.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.